Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cara Therapeutics Inc CARA

Healthcare Cannabis
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated... see more

Recent & Breaking News (NDAQ:CARA)

Legal Cannabis Market Expects Growth

PR Newswire November 23, 2016

Cara Therapeutics to Webcast Presentation at the 28th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 22, 2016

Biotech Stocks Press Forward with Drug-Development Advancements

PR Newswire November 17, 2016

Legal Cannabis Industry Growth in 2016

PR Newswire November 16, 2016

Biotech-Cannabis Stocks Move on Election, State Ballots

PR Newswire November 15, 2016

Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, Cara Therapeutics, Emergent BioSolutions, and Alder Biopharma

PR Newswire November 14, 2016

The Expectations of the Legal Cannabis Market After Elections

PR Newswire November 11, 2016

All Eyes on the Legalization of Cannabis

PR Newswire November 8, 2016

Cara Therapeutics to Webcast Presentation at the Stifel 2016 Healthcare Conference

GlobeNewswire November 8, 2016

Cannabis Legalization on the Ballots This Election Year

PR Newswire November 7, 2016

Mid-Morning Market Update: Markets Open Lower; Humana Beats Q3 Estimates

Benzinga.com  November 4, 2016

Cara Therapeutics Reports Third Quarter 2016 Financial Results

GlobeNewswire November 3, 2016

The Growth in Cigarette Alternatives

PR Newswire October 31, 2016

Cara Therapeutics to Present Data at Kidney Week 2016

GlobeNewswire October 31, 2016

Cara Therapeutics to Announce Third Quarter 2016 Financial Results on November 3, 2016

GlobeNewswire October 27, 2016

Possible Cannabis Reform Heats Up

PR Newswire October 26, 2016

Support for the Cannabis Industry at an All Time High

PR Newswire October 25, 2016

10 Biggest Mid-Day Gainers For Thursday

Benzinga.com  October 13, 2016

H.C. Wainwright Is Bullish On Cara Therapeutics Shares

Benzinga.com  October 13, 2016

Cara Therapeutics to Participate in October Medical Meetings

GlobeNewswire October 12, 2016